199 related articles for article (PubMed ID: 30833467)
1. Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.
Jungtrakoon P; Shirakawa J; Buranasupkajorn P; Gupta MK; De Jesus DF; Pezzolesi MG; Panya A; Hastings T; Chanprasert C; Mendonca C; Kulkarni RN; Doria A
Diabetes; 2019 May; 68(5):1084-1093. PubMed ID: 30833467
[TBL] [Abstract][Full Text] [Related]
2. A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia.
Xian X; Liao L; Shu W; Li H; Qin Y; Yan J; Luo J; Lin FQ
Cell Physiol Biochem; 2018; 47(5):1989-1997. PubMed ID: 29969779
[TBL] [Abstract][Full Text] [Related]
3. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951336
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951337
[TBL] [Abstract][Full Text] [Related]
6. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family.
Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G
Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472
[TBL] [Abstract][Full Text] [Related]
7. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
[TBL] [Abstract][Full Text] [Related]
8. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
[TBL] [Abstract][Full Text] [Related]
9. Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
Ghaemi N; Ghahraman M; Abbaszadegan MR; Baradaran-Heravi A; Vakili R
J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):199-201. PubMed ID: 24072090
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
Oishi K; Hofmann S; Diaz GA; Brown T; Manwani D; Ng L; Young R; Vlassara H; Ioannou YA; Forrest D; Gelb BD
Hum Mol Genet; 2002 Nov; 11(23):2951-60. PubMed ID: 12393806
[TBL] [Abstract][Full Text] [Related]
11. Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report.
Katipoğlu N; Karapinar TH; Demir K; Aydin Köker S; Nalbantoğlu Ö; Ay Y; Korkmaz HA; Oymak Y; Yıldız M; Tunç S; Hazan F; Vergin C; Ozkan B
Arch Argent Pediatr; 2017 Jun; 115(3):e153-e156. PubMed ID: 28504500
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
Enogieru OJ; Koleske ML; Vora B; Ngo H; Yee SW; Chatad D; Sirota M; Giacomini KM
AAPS J; 2021 Mar; 23(2):35. PubMed ID: 33649974
[TBL] [Abstract][Full Text] [Related]
13. Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
Manimaran P; Subramanian VS; Karthi S; Gandhimathi K; Varalakshmi P; Ganesh R; Rathinavel A; Said HM; Ashokkumar B
Clin Chim Acta; 2016 Jan; 452():44-9. PubMed ID: 26549656
[TBL] [Abstract][Full Text] [Related]
14. Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
Mozzillo E; Melis D; Falco M; Fattorusso V; Taurisano R; Flanagan SE; Ellard S; Franzese A
Pediatr Diabetes; 2013 Aug; 14(5):384-7. PubMed ID: 23289844
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
Lagarde WH; Underwood LE; Moats-Staats BM; Calikoglu AS
Am J Med Genet A; 2004 Mar; 125A(3):299-305. PubMed ID: 14994241
[TBL] [Abstract][Full Text] [Related]
16. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
[TBL] [Abstract][Full Text] [Related]
17. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
Fleming JC; Tartaglini E; Steinkamp MP; Schorderet DF; Cohen N; Neufeld EJ
Nat Genet; 1999 Jul; 22(3):305-8. PubMed ID: 10391222
[TBL] [Abstract][Full Text] [Related]
18. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
[TBL] [Abstract][Full Text] [Related]
19. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
[TBL] [Abstract][Full Text] [Related]
20. Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.
Fleming JC; Tartaglini E; Kawatsuji R; Yao D; Fujiwara Y; Bednarski JJ; Fleming MD; Neufeld EJ
Mol Genet Metab; 2003; 80(1-2):234-41. PubMed ID: 14567973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
